share_log

HC Wainwright & Co. Downgrades Asensus Surgical to Neutral, Lowers Price Target to $0.35

HC Wainwright & Co. Downgrades Asensus Surgical to Neutral, Lowers Price Target to $0.35

HC Wainwright & Co.将Asensus Surgical的评级下调至中性,将目标股价下调至0.35美元
Benzinga ·  04/04 06:06

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Asensus Surgical (AMEX:ASXC) from Buy to Neutral and lowers the price target from $2 to $0.35.

HC Wainwright & Co. 分析师Swayampakula Ramakanth将Asensus Surgical(AMEX: ASXC)的评级从买入下调至中性,并将目标股价从2美元下调至0.35美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发